ASTRAZENECA TO PARTICIPATE IN US FDA ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE AstraZeneca today announced it will participate in the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee meeting on 14 April 2015 to discuss the results of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR) trial for ONGLYZA® (saxagliptin) and Kombiglyze® XR (saxagliptin and metformin HCI extended-release). The topic of the Advisory Committee is based on an ongoing review of a previously submitted supplemental New Drug Application to the FDA for ONGLYZA and Kombiglyze XR. AstraZeneca welcomes the opportunity to discuss the SAVOR cardiovascular outcomes data with the Advisory Committee. About SAVOR The SAVOR (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza (saxagliptin) was a randomised, double-blind, controlled trial evaluating the effect of saxagliptin on the incidence of major adverse cardiovascular events in patients with type 2 diabetes mellitus and at an elevated risk for CV events. The SAVOR study was conducted as part of the Postmarketing Requirement for the US New Drug Application approval of Onglyza in accordance with the 2008 FDA guidance, "Diabetes Mellitus - Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes." The primary objective of this trial was to determine that the addition of saxagliptin to standard of care in this patient population did not significantly increase the incidence of major cardiovascular events as compared to placebo. About DPP-4 inhibitors Saxagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Incretin hormones decrease elevated blood sugar levels (glucose) by increasing the body's utilisation of sugar, mainly through increasing insulin production in the pancreas, and by reducing the liver's production of glucose. DPP-4 inhibitors work by increasing the activity of the incretin hormones, increasing the release of insulin when glucose levels are elevated and reducing the levels of sugar produced by the liver. About Type 2 Diabetes Diabetes is estimated to affect 29.1 million people in the US and more than 382 million people worldwide. The prevalence of diabetes is projected to reach more than 592 million people worldwide by 2035. Type 2 diabetes accounts for approximately 90-95 percent of all cases of diagnosed diabetes in the US. Type 2 diabetes is a chronic disease characterised by pathophysiologic defects leading to elevated glucose levels. Significant unmet needs still exist, as many patients remain inadequately controlled on their current glucose-lowering regimen. It is estimated that more than half of people living with type 2 diabetes are not achieving recommended HbA1c goals based on guidelines established by professional societies and advocacy organisations for diabetes management. About AstraZeneca AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com CONTACTS Media Enquiries Esra Erkal-Paler +44 20 7604 8030 (UK/Global) Vanessa Rhodes +44 20 7604 8037 (UK/Global) Ayesha Bharmal +44 20 7604 8034 (UK/Global) Jacob Lund +46 8 553 260 20 (Sweden) Michele Meixell + 1 302 885 6351 (US) Investor Enquiries Thomas Kudsk Larsen +44 20 7604 8199 mob: +44 7818 524185 Karl Hård +44 20 7604 8123 mob: +44 7789 654364 Craig Marks +44 20 7604 8591 mob: +44 7881 615764 Eugenia Litz +44 20 7604 8233 mob: +44 7884 735627 Christer Gruvris +44 20 7604 8126 mob: +44 7827 836825 4 March 2015 - ENDS -
AZ TO PARTICIPATE IN US FDA EMDAC ASTRAZENECA TO
Top 10 Most Recent News Articles
AllyGPO Shines as Top Innovator in Health Tech
Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...
Continue ReadingAlif Semiconductor Unveils StartKit for Edge AI MCU Fam
Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....
Continue Reading
1M+ California Homes Face Extreme Wildfire Risk Revealed
Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...
Continue Reading
MADD, Uber Rally at Capital Invitational for Safe Choices
Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...
Continue Reading
Life Flower Celebrates 16 Years with Dog Adoption Event
A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...
Continue Reading
Nashville Benefit Concert Supports Animal Rescue Mission
Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...
Continue Reading
Strategic Hire: Whisenhunt Joins FlexScreen & RiteScreen
Shaking Up the Window Screens Biz If you've been grinding in the window and door game, you know it's not an industry with a lot of buzz, but here comes a shot of caffeine. FlexScreen and RiteScreen just snagged David Whisenhunt to rev up their sales machine. Who's David Whisenhunt? Well, he's no rookie. With over two decades deep in the fenestration field, Whisenhunt...
Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel
Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...
Continue Reading
Spot the Signs: Early Gum Disease Insights from Experts
Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....
Continue Reading
Leidos' Autonomous Vessels Chart Bold Naval Waters
Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...
Continue ReadingTop 5 Most Recently Viewed Articles
Transport Credit Union™ Unveils Brand Refresh for 2025 Vision
Transport Credit Union™ Marks a New Era with Rebranding With a proud legacy spanning over 86 years, Transport Credit Union has stepped into a new chapter by embracing a fresh brand identity. Formerly known as Coast2Coast Financial Credit Union, this transformation emphasizes their dedication to the hardworking individuals within the transportation sector. The heart of...
Continue Reading
Eastern International Plans Initial Public Offering of 1.6M Shares
Eastern International’s IPO Announcement Eastern International (ELOG) has recently made headlines with its filing for an initial public offering (IPO) that intends to offer 1,600,000 shares at a price ranging from $4 to $5 per share. This move marks a pivotal moment for the company as it explores avenues for growth and capital influx. Understanding the IPO Process The...
Continue Reading
Purdue University Unveils Neil Armstrong Space Prize Initiative
Purdue University Unveils Neil Armstrong Space Prize Initiative Purdue University, a distinguished name in space education, has launched an exciting new opportunity for international recognition — the Neil Armstrong Space Prize. This prestigious award is dedicated to showcasing excellence in space discovery, innovation, and downright extraordinary human achievement over...
Continue Reading
Ming Shing Group's Strategic Bitcoin Investment for Growth
Significant Business Development for Ming Shing Group Ming Shing Group Holdings Limited (NASDAQ: MSW), a Hong Kong-based company specializing in wet trades works, has recently announced an exciting update regarding its business development. This news highlights the company's commitment to financial growth through strategic investments. Investment in Bitcoin The...
Continue Reading
Kyndryl Launches AI-Driven SAP Modernization Strategy
Kyndryl Introduces Innovative SAP Modernization Strategy Kyndryl has recently announced a groundbreaking approach to enhance SAP modernization, leveraging agentic AI technology. This new strategy underscores Kyndryl's commitment to providing efficient and effective services tailored for customers looking to navigate their SAP transformation journey smoothly. The Clean...
Continue Reading